[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Siegel, R.L., Miller, K.D., Wagle, N.S., et al. (2023) Cancer Statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17-48. https://doi.org/10.3322/caac.21763
|
[3]
|
Goldman, A.L., Bhasin, S., Wu, F.C.W., et al. (2017) A Reappraisal of Testosterone’s Binding in Circulation: Physiological and Clinical Implications. Endocrine Reviews, 38, 302-324. https://doi.org/10.1210/er.2017-00025
|
[4]
|
Geniole, S.N. and Car-ré, J.M. (2018) Human Social Neuroendocrinology: Review of the Rapid Effects of Testosterone. Hormones and Be-havior, 104, 192-205. https://doi.org/10.1016/j.yhbeh.2018.06.001
|
[5]
|
Cunningham, G.R., Stephens-Shields, A.J., Rosen, R.C., et al. (2015) Association of Sex Hormones with Sexual Function, Vitality, and Physical Function of Symptomatic Older Men with Low Testosterone Levels at Baseline in the Testosterone Trials. The Journal of Clinical Endocrinology & Metabolism, 100, 1146-1155.
https://doi.org/10.1210/jc.2014-3818
|
[6]
|
Zhu, A., Andino, J., Daignault-Newton, S., et al. (2022) What Is a Nor-mal Testosterone Level for Young Men? Rethinking the 300 ng/dL Cutoff for Testosterone Deficiency in Men 20-44 Years Old. Journal of Urology, 208, 1295-1302.
https://doi.org/10.1097/JU.0000000000002928
|
[7]
|
Kutlikova, H.H., Durdiaková, J.B., Wagner, B., et al. (2020) The Effects of Testosterone on the Physiological Response to Social and Somatic Stressors. Psychoneuroendocrinology, 117, Article ID: 104693.
https://doi.org/10.1016/j.psyneuen.2020.104693
|
[8]
|
Mchenry, J., Carrier, N., Hull, E. and Kabbaj, M. (2014) Sex Differences in Anxiety and Depression: Role of Testosterone. Frontiers in Neuroendocrinology, 35, 42-57. https://doi.org/10.1016/j.yfrne.2013.09.001
|
[9]
|
Welén, K. and Damber, J.E. (2022) Androgens, Aging, and Pros-tate Health. Reviews in Endocrine and Metabolic Disorders, 23, 1221-1231. https://doi.org/10.1007/s11154-022-09730-z
|
[10]
|
Desai, K., Mcmanus, J.M. and Sharifi, N. (2021) Hormonal Therapy for Prostate Cancer. Endocrine Reviews, 42, 354-373. https://doi.org/10.1210/endrev/bnab002
|
[11]
|
Morgentaler, A., Bruning III, C.O. and Dewolf, W.C. (1996) Occult Prostate Cancer in Men with Low Serum Testosterone Levels. JAMA, 276, 1904-1906. https://doi.org/10.1001/jama.1996.03540230054035
|
[12]
|
Morgentaler, A. and Rhoden, E.L. (2006) Prevalence of Prostate Cancer among Hypogonadal Men with Prostate-Specific Antigen Levels of 4.0 ng/mL or Less. Urology, 68, 1263-1267.
https://doi.org/10.1016/j.urology.2006.08.1058
|
[13]
|
Shin, B.S., Hwang, E.C., Im, C.M., et al. (2010) Is a De-creased Serum Testosterone Level a Risk Factor for Prostate Cancer? A Cohort Study of Korean Men. Korean Journal of Urology, 51, 819-823.
https://doi.org/10.4111/kju.2010.51.12.819
|
[14]
|
Gao, Y., Jiang, C.Y., Mao, S.K., et al. (2016) Low Serum Testos-terone Predicts Upgrading and Upstaging of Prostate Cancer after Radical Prostatectomy. Asian Journal of Andrology, 18, 639-643.
https://doi.org/10.4103/1008-682X.169984
|
[15]
|
Røder, M.A., Christensen, I.J., Berg, K.D., et al. (2012) Serum Testosterone Level as a Predictor of Biochemical Failure after Radical Prostatectomy for Localized Prostate Cancer. BJU International, 109, 520-524.
https://doi.org/10.1111/j.1464-410X.2011.10335.x
|
[16]
|
Dai, B., Qu, Y., Kong, Y., et al. (2012) Low Pretreatment Serum Total Testosterone Is Associated with a High Incidence of Gleason Score 8-10 Disease in Prostatectomy Speci-mens: Data from Ethnic Chinese Patients with Localized Prostate Cancer. BJU International, 110, E667-E672. https://doi.org/10.1111/j.1464-410X.2012.11465.x
|
[17]
|
Massengill, J.C., Sun, L., Moul, J.W., et al. (2003) Pre-treatment Total Testosterone Level Predicts Pathological Stage in Patients with Localized Prostate Cancer Treated with Radical Prostatectomy. Journal of Urology, 169, 1670-1675.
https://doi.org/10.1097/01.ju.0000062674.43964.d0
|
[18]
|
Gann, P.H., Hennekens, C.H., Ma, J., et al. (1996) Pro-spective Study of Sex Hormone Levels and Risk of Prostate Cancer. Journal of the National Cancer Institute, 88, 1118-1126. https://doi.org/10.1093/jnci/88.16.1118
|
[19]
|
Shaneyfelt, T., Husein, R., Bubley, G. and Mantzoros, C.S. (2000) Hormonal Predictors of Prostate Cancer: A Meta-Analysis. Journal of Clinical Oncology, 18, 847-853. https://doi.org/10.1200/JCO.2000.18.4.847
|
[20]
|
Platz, E.A., Leitzmann, M.F., Rifai, N., et al. (2005) Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Pros-tate-Specific Antigen Era. Cancer Epidemiology, Biomarkers & Prevention, 14, 1262-1269. https://doi.org/10.1158/1055-9965.EPI-04-0371
|
[21]
|
Porcaro, A.B., Petroziello, A., Brunelli, M., et al. (2016) High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy. Urologia Internationalis, 96, 470-478. https://doi.org/10.1159/000443742
|
[22]
|
Salonia, A., Abdollah, F., Capitanio, U., et al. (2013) Preoperative Sex Steroids Are Significant Predictors of Early Biochemical Recurrence after Radical Prostatectomy. World Journal of Urology, 31, 275-280.
https://doi.org/10.1007/s00345-012-0856-7
|
[23]
|
Yamamoto, S., Yonese, J., Kawakami, S., et al. (2007) Preopera-tive Serum Testosterone Level as an Independent Predictor of Treatment Failure following Radical Prostatectomy. Euro-pean Urology, 52, 696-701.
https://doi.org/10.1016/j.eururo.2007.03.052
|
[24]
|
Ahmadi, H., Allameh, F., Baradaran, N., et al. (2011) Circulating Sex Hormones Play No Role in the Association between Sexual Activity and the Risk of Prostate Cancer. The Journal of Sexual Medicine, 8, 905-913.
https://doi.org/10.1111/j.1743-6109.2010.02115.x
|
[25]
|
Morales, A. and Siemens, D.R. (2022) Testosterone Ther-apy and Prostate Cancer: Incorporating Low-Level Evidence into Practical Recommendations. Urologic Clinics of North America, 49, 573-582.
https://doi.org/10.1016/j.ucl.2022.07.002
|
[26]
|
Haider, A., Zitzmann, M., Doros, G., et al. (2015) Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of 3 Registries. Journal of Urology, 193, 80-86.
https://doi.org/10.1016/j.juro.2014.06.071
|
[27]
|
Khera, M., Crawford, D., Morales, A., et al. (2014) A New Era of Testosterone and Prostate Cancer: From Physiology to Clinical Implications. European Urology, 65, 115-123. https://doi.org/10.1016/j.eururo.2013.08.015
|
[28]
|
Kaplan, A.L., Trinh, Q.D., Sun, M., et al. (2014) Testosterone Replacement Therapy following the Diagnosis of Prostate Cancer: Outcomes and Utilization Trends. The Journal of Sex-ual Medicine, 11, 1063-1070.
https://doi.org/10.1111/jsm.12429
|
[29]
|
Pastuszak, A.W., Pearlman, A.M., Lai, W.S., et al. (2013) Testosterone Replacement Therapy in Patients with Prostate Cancer after Radical Prostatectomy. Journal of Urology, 190, 639-644. https://doi.org/10.1016/j.juro.2013.02.002
|
[30]
|
Leibowitz, R.L., Dorff, T.B., Tucker, S., et al. (2010) Testosterone Replacement in Prostate Cancer Survivors with Hypogonadal Symptoms. BJU International, 105, 1397-1401. https://doi.org/10.1111/j.1464-410X.2009.08980.x
|
[31]
|
Lenfant, L., Leon, P., Cancel-Tassin, G., et al. (2020) Testosterone Replacement Therapy (TRT) and Prostate Cancer: An Updated Systematic Review with a Focus on Previ-ous or Active Localized Prostate Cancer. Urologic Oncology: Seminars and Original Investigations, 38, 661-670. https://doi.org/10.1016/j.urolonc.2020.04.008
|
[32]
|
Kaplan, A.L., Hu, J.C., Morgentaler, A., et al. (2016) Testos-terone Therapy in Men with Prostate Cancer. European Urology, 69, 894-903. https://doi.org/10.1016/j.eururo.2015.12.005
|
[33]
|
Kumar, R., Sena, L.A., Denmeade, S.R. and Kachhap, S. (2023) The Testosterone Paradox of Advanced Prostate Cancer: Mechanistic Insights and Clinical Implications. Nature Reviews Urology, 20, 265-278.
https://doi.org/10.1038/s41585-022-00686-y
|